• 2025-11-26 08:01:00

Artificial Intelligence (AI) is rapidly transforming healthcare in Australia, offering innovative solutions to meet the growing demands of an aging population and chronic disease management. With the AI healthcare market projected to reach AUD 1.78 billion by 2030, AI's potential to enhance early diagnosis and optimize treatments is substantial. Despite challenges like data fragmentation and regulatory complexities, AI is set to revolutionize healthcare delivery across the country.

• 2025-11-26 06:54:12

On 2 October 2025, the Singapore Health Sciences Authority (HSA) conducted the Health Products Regulatory Conference 2025, which was held jointly with the Singapore Manufacturing Federation (SMF) MedTech Day. The event elevated the theme: "Advancing Singapore's Medtech Ecosystem: be connected, collaborative, and future-ready".
During the conference, the HSA's Medical Device Cluster (MDC) shared insights on the evolving regulatory landscape, examining both present developments and anticipated future trends in the field, especially related to digital health products.

• 2025-09-24 10:06:53

Malaysia has emerged as a dental powerhouse, attracting international patients with world-class treatments at affordable prices, while fueling one of ASEAN's fastest-growing dental device markets. With over 3,700 private clinics and a nationwide network of public facilities, the country is well-positioned to meet rising demand driven by medical tourism and a tech-savvy private sector. Yet, Malaysia also faces a domestic oral health challenge, highlighting both the urgency and the opportunity for innovation.

• 2025-08-25 03:07:39

Indonesia's Ministry of Health has issued Decision Letter No. HK.01.07/MENKES/736/2025, which outlines the types of medical devices that may be sold by retail business operators. This regulation clarifies the criteria that these devices must meet and the obligations that retailers must follow when engaging in the sale of medical device. It also provides a reference list of medical devices that are eligible for retail distribution under this policy.

• 2025-07-10 09:14:07

The Health Science Agency (HSA) are pleased to announce the launch of SHARE (Singapore Health Product Access and Regulatory E-System). This new system will replace the existing MEDICS system for medical device product registrations and license submissions.
SHARE was first time introduced to the stakeholders during an Industry Briefing on May 21, 2025. During the session, HSA highlighted key changes implemented for medical devices on SHARE, demonstrated the user interface and key features, and outlined the timeline for the full transition from MEDICS to SHARE, effective July 14, 2025.

• 2025-06-03 06:29:29

Thailand's medical tourism industry offers a unique blend of affordable, high-quality healthcare and a captivating tourist experience. Patients worldwide are attracted by the diverse range of medical specialties, advanced technology, and international accreditation of Thai medical facilities. The country's growing demand for medical devices and supportive government policies further solidify its position as a leading medical tourism destination.

• 2025-03-26 06:09:21

While the Philippines' ambitious Universal Health Care Act and substantial government investment are creating a rapidly expanding market for medical devices, the nation's overwhelming reliance on imports starkly contrasts with its limited domestic manufacturing capabilities. This situation, however, creates an opening for overseas manufacturers to provide the needed medical devices and take advantage of the increasing market.

• 2025-02-20 10:09:30

Decree No. 04/2025/NĐ-CP, released on January 1st, 2025, by Vietnam MOH, extending the validity of import license until June 30, 2025, on the Decree amending and supplementing of Clause 2, Clause 3, and Clause 4, Article 76 of Decree No. 98/2021/ND-CP, as revised by Decree No. 07/2023/ND-CP, regarding medical device management.

• 2024-12-16 09:42:20

South Korea is transforming healthcare with AI, enabling personalized nutrition, early disease detection, and proactive health management. AI systems, like one that diagnosed lung cancer with 94% accuracy, showcase its potential. The technology also accelerates drug development, opening new opportunities for AI-powered medical device companies.

• 2024-10-10 10:03:44

The ASEAN region is rapidly emerging as a vital player in the global healthcare industry, offering immense opportunities for growth and expansion. For medical device companies looking to enter this dynamic market, partnering with Qualtech Consulting Corporation provides the expertise, support, and local knowledge necessary to navigate the complexities of regulatory approval and achieve success. Don’t miss the chance to expand your business in one of the world’s most exciting healthcare markets—let Qualtech guide you every step of the way.